Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Rhea-AI Summary
Enovis (NYSE: ENOV) will host a conference call and live webcast to discuss fourth quarter and full year 2025 results on Thursday, February 26, 2026 at 8:30 a.m. ET. An earnings press release will be issued earlier that morning. The live webcast and presentation will be available from the Investors section of Enovis' website at www.enovis.com. U.S. dial-in is (833) 685-0901 and international dial-in is (412) 317-5715. A replay and presentation materials will be posted on the Enovis website later the same day.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ENOV declined 2.29%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: CNMD up 1.22%, NVCR up 3.58%, while AORT, UFPT, and IART are modestly negative, suggesting stock-specific rather than sector-driven dynamics.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 24 | Earnings call notice | Neutral | -0.0% | Announced Q3 2025 results call and investor conference participation details. |
| Jul 08 | Earnings call notice | Neutral | +2.4% | Set date and access details for Q2 2025 results conference call. |
| Apr 17 | Earnings call notice | Neutral | +2.6% | Announced Q1 2025 results call timing and participation information. |
| Jan 29 | Earnings call notice | Neutral | -0.7% | Outlined Q4 and full-year 2024 results call schedule and dial-in details. |
Earnings conference-call announcements with tag conferences,earnings have historically led to modest stock moves, with an average move of 1.42% around such events.
Recent Enovis history shows a consistent cadence of quarterly earnings call announcements with limited immediate price impact. Prior calls for Q1, Q2, Q3 2025 and the 2024 year-end results, all tagged conferences,earnings, saw single-digit percentage moves between about -1% and +3%. This new Q4 and full-year 2025 call notice fits that established pattern of routine investor communication without new financial figures.
Historical Comparison
Past conferences,earnings notices for ENOV led to average moves of 1.42%, suggesting this Q4 and FY 2025 call announcement is consistent with prior routine communications.
Company has maintained a regular pattern of quarterly and year-end earnings call announcements for 2024–2025, reinforcing a predictable investor relations cadence.
Market Pulse Summary
This announcement sets the date and access details for Enovis’s fourth quarter and full year 2025 results call on February 26, 2026. It continues a regular pattern of quarterly conferences,earnings notices that historically produced modest stock moves. Investors may focus on how upcoming results relate to prior 2025 quarters and earlier disclosures, using the call to assess trends in performance and strategy execution.
AI-generated analysis. Not financial advice.
Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
When will Enovis (ENOV) report fourth quarter and full year 2025 results?
How can investors listen to the Enovis (ENOV) earnings call on February 26, 2026?
Will Enovis (ENOV) publish an earnings press release before the February 26, 2026 call?
Where can I find the Enovis (ENOV) webcast replay and presentation after the call?
What dial-in numbers should I use for the Enovis (ENOV) February 26, 2026 call?
